Editorial ABLE: A new and improved amphotericin B for visceral leishmaniasis?

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 5, 2009, Pages 689-690

  Berman, Jonathan ^a  

^a Fast Track Drugs and Biologies LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY; LIPID EMULSION; MILTEFOSINE; PAROMOMYCIN; AMPHOTERICIN B; ANTIPROTOZOAL AGENT; LIPID;

ANEMIA; BANGLADESH; BONE PAIN; CHILL; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; ENDEMIC DISEASE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; INDIA; LEISHMANIA; LIVER TOXICITY; NEPAL; NEPHROTOXICITY; NEUTROPENIA; PANCREATITIS; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; VISCERAL LEISHMANIASIS; CHEMISTRY; DRUG ADMINISTRATION; EMULSION; NOTE;

AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG ADMINISTRATION SCHEDULE; EMULSIONS; HUMANS; LEISHMANIASIS, VISCERAL; LIPIDS;

EID: 66149141810     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.689     Document Type: Editorial

References (8)

1. Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, Kumar PC, Murray HW, 2000. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 31:1104-1107.
2. Sundar S, Singh A, Agarwal D, Rai M, Agrawal N, Chakravarty J, 2009. Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis. Am J Trop Med Hyg 80:700-703.
3. Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J, 2002. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 347:1739-1746.
4. Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK, 2007. Injectable paromomycin for visceral leishmaniasis in India. N Engl J Med 356:2571-2581.
5. Sundar S, Agrawal G, Rai M, Makharia MK, Murray HW, 2001. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial. BMJ 323: 419-422.
6. Sundar S, Jha TK, Thakur CP, Mishra M, Singh VP, Buffels R, 2003. Single-dose liposomal amphotericin B in the treatment of vis-ceral leishmaniasis in India: a multicenter study. Clin Infect Dis 37:800-804.
7. Sundar S, Jha TK, Thakur CP, Mishra M, Singh VR, Buffels R. 2002. Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. Am J Trop Med Hyg 66:143-146.
8. Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lai C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H, Ganguly NK, 2007. Phase 4 trial of miltefosine for the treatment of Indian visceral leish-maniasis. J Infect Dis 196:591-598.